C Technologies Revenue and Competitors

Bridgewater, NJ USA

Location

N/A

Total Funding

Design

Industry

Estimated Revenue & Valuation

  • C Technologies's estimated annual revenue is currently $18.5M per year.(i)
  • C Technologies's estimated revenue per employee is $243,000

Employee Data

  • C Technologies has 76 Employees.(i)
  • C Technologies grew their employee count by 38% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.3M20328%N/AN/A
#2
$1M8-11%N/AN/A
#3
$92M3039%N/AN/A
#4
$18.5M7638%N/AN/A
#5
$69M258-1%N/AN/A
#6
$50.8M1902%N/AN/A
#7
$4.3M25-4%N/AN/A
#8
$3.9M23-8%N/AN/A
#9
$0.1M10%N/AN/A
#10
$3.6M21-25%N/AN/A
Add Company

What Is C Technologies?

Now well into its third decade, C Technologies, Inc. continues to design and manufacture fiber optic assemblies, instrumentation and systems for spectroscopy applications. With customers spanning a wide range of markets including: pharmaceutical, biotech, laboratory instruments, government, industrial process, research institutions and academia, C Technologies, Inc. utilizes its years of experience to help create innovative tools, processes, and solutions for analytical and process challenges. C Technologies' products are currently being used to measure and characterize the universe, to help produce the chips that power our digital lives, to monitor the health of our oceans, to deliver healing through laser therapies, and to support the development of new biologic and pharmaceutical products. Always curious and looking to learn and improve, C Technologies Inc. continues to deliver innovative technologies and looks forward to new challenges and opportunities to explore.

keywords:N/A

N/A

Total Funding

76

Number of Employees

$18.5M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

C Technologies News

2022-04-20 - WELL Health Technologies Corp. (TSE:WELL) Given Consensus ...

The average 12-month price objective among analysts that have covered the stock in the last year is C$10.63. Several equities research analysts...

2022-04-17 - HCL Technologies Ltd. ADR (HCTHY) CEO C Vijayakumar on Q4 2022 Results - Earnings Call Transcript

HCL Technologies Ltd. ADR (HCTHY) CEO C Vijayakumar on Q4 2022 Results - Earnings Call Transcript. Apr. 21, 2022 4:01 PM ETHCL Technologies Ltd. ADR (HCTHY).

2022-04-17 - NexHealth hits unicorn status with $125M series C for patient ...

The company also offers a universal application programming interface (API) to speed the pace of health tech innovations by making it easier...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.3M794%N/A
#2
$12.3M8557%N/A
#3
$10.2M852%N/A
#4
$30M859%N/A
#5
$18.3M913%N/A